Ikarian Capital, LLC Puma Biotechnology, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.64 - $3.3 $81,742 - $164,481	-49,843 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $33,534 - $47,494	-5,058 Reduced 9.21%	49,843 $349,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $1.61 Million - $3.74 Million	-256,352 Reduced 82.36%	54,901 $463,000
Q4 2019 Jan 31, 2020	BUY	$6.5 - $10.73 $2.02 Million - $3.34 Million	311,253 New	311,253 $2.72 Million

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.